Cytek Biosciences Inc (CTKB)
Receivables turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 193,014 | 183,117 | 175,594 | 166,060 | 164,036 | 155,086 | 148,985 | 139,234 | |||
| Receivables | US$ in thousands | 55,928 | 55,402 | 49,624 | 43,100 | 48,864 | 39,636 | 36,811 | 30,406 | 29,760 | 29,450 | 24,029 |
| Receivables turnover | 3.45 | 3.31 | 3.54 | 3.85 | 3.36 | 3.91 | 4.05 | 4.58 |
December 31, 2023 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $193,014K ÷ $55,928K
= 3.45
The receivables turnover of Cytek Biosciences Inc has shown some fluctuation over the past few quarters. It decreased from 3.91 in the third quarter of 2022 to 3.36 in the fourth quarter of 2022, before increasing to 3.85 in the first quarter of 2023. It further increased to 3.54 in the second quarter of 2023 before declining slightly to 3.31 in the third quarter of 2023.
Overall, the receivables turnover indicates how efficiently the company is able to collect payments from its customers. A higher turnover ratio suggests that the company is collecting payments more quickly, which is generally favorable. However, fluctuations in this ratio could be due to changes in credit policies, customer payment behavior, or sales volume.
It is important for Cytek Biosciences Inc to keep track of its receivables turnover and investigate any significant changes to ensure that the company's liquidity and cash flow are being managed effectively.
Peer comparison
Dec 31, 2023